Aptevo Therapeutics Inc. priced a public offering of common stock and warrants, receiving net proceeds of approximately $4.0 million for clinical development and working capital.
AI Assistant
APTEVO THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.